Featured Research

from universities, journals, and other organizations

New software aids breast cancer risk assessment

Date:
May 8, 2014
Source:
Asociación RUVID
Summary:
DMScan, a new software to aid breast cancer risk assessment, has been developed by researchers to aid in the risk assessment of breast cancer. From the images obtained in mammograms, the software objectively quantifies breast density, a value directly related to the risk of this pathology. Breast cancer is the malignant tumor with the highest incidence in women from around the world, with more than 1.6 million new cases diagnosed every year.

Rafael Llobet (UPV) and Josefa Miranda (FISABIO).
Credit: Image courtesy of Asociación RUVID

Researchers of the Universitat Politècnica de València, in collaboration with the Instituto de Salud Carlos III (Institute of Health Carlos III, ISCIII, in Spanish) and the Foundation for the Health and Biomedical Research of the Comunitat Valenciana (Fisabio), have developed DMScan, new software to aid breast cancer risk assessment. From the images obtained in mammograms, the software objectively quantifies breast density, a value directly related to the risk of this pathology.

"The breast is basically composed of adipose tissue and fibroglandular tissue; the density is the proportion of the latter to the breast size. Our software quantifies this value, distinguishing dense tissue from fat tissue. It offers a continuous and much more objective measurement than the doctors give today, based on a visual inspection. This is therefore a new aid to breast cancer diagnosis," says Rafael Llobet, researcher at the Computer Technology Institute (ITI, in Spanish) of the Universitat Politècnica de València.

The software can work in automatic and assisted mode. In the latter, the user can adjust different parameters associated to the density calculation. "So far, the assisted read-out, done by an expert radiologist, provides better-quality information, but the availability of an automatic read-out is of great interest in an initial assessment of density when processing a large number of mammogram," states Rafael Llobet.

Shape recognition, learning and computer vision

DMScan incorporates shape recognition, automatic learning and computer vision techniques. It also includes a statistical model created from a database of 650 mammograms, which allows it to classify new tests. "We use these images in order to train the system, as reference standards, so when a new mammogram is introduced into the system it can compare it to that corpus and classify it," explains Rafael Llobet.

Research

Besides its medical application, DMScan is interesting for research purposes and for studies related to breast density from a large number of images. "For example, if breast density could be related to a certain genotype," adds Rafael Llobet.

About breast cancer

According to the study of the researchers from the UPV, FISABIO and ISCIII, "women with denser breasts have more breast cancer risk. However, it must be taken into account that breast density decreases with age and with the body mass index, two factors also related to the probability of having breast cancer and that have been taken into account in this work."

Breast cancer is the malignant tumor with the highest incidence in women from around the world, with more than 1.6 million new cases diagnosed every year. In Spain, there are more than 25,000 new diagnoses every year. Despite the high survival rate from this tumor, it still causes more than 6,000 deaths every year among Spanish women.


Story Source:

The above story is based on materials provided by Asociación RUVID. Note: Materials may be edited for content and length.


Journal Reference:

  1. Rafael Llobet, Marina Pollán, Joaquín Antón, Josefa Miranda-García, María Casals, Inmaculada Martínez, Francisco Ruiz-Perales, Beatriz Pérez-Gómez, Dolores Salas-Trejo, Juan-Carlos Pérez-Cortés. Semi-automated and fully automated mammographic density measurement and breast cancer risk prediction. Computer Methods and Programs in Biomedicine, 2014; DOI: 10.1016/j.cmpb.2014.01.021

Cite This Page:

Asociación RUVID. "New software aids breast cancer risk assessment." ScienceDaily. ScienceDaily, 8 May 2014. <www.sciencedaily.com/releases/2014/05/140508095454.htm>.
Asociación RUVID. (2014, May 8). New software aids breast cancer risk assessment. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/05/140508095454.htm
Asociación RUVID. "New software aids breast cancer risk assessment." ScienceDaily. www.sciencedaily.com/releases/2014/05/140508095454.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins